Suppr超能文献

[过氧化物酶体增殖与肝癌致癌过程]

[Proliferation of peroxisomes and the hepatocarcinogenic process].

作者信息

Palut D

机构信息

Zakład Toksykologii Srodowiskowej, Państwowy Zakład Higieny, Warszawa.

出版信息

Rocz Panstw Zakl Hig. 1997;48(1):1-11.

PMID:9273657
Abstract

Peroxisome proliferators are diverse group of chemicals which are regarded as rodent hepatocarcinogens and/or- liver tumor promoters. These compounds when administered to rats and mice produce a dramatic increase in the size and number of hepatic peroxisomes and increase in activities of enzymes involved in beta-oxidation of fatty acids. Peroxisome proliferation is accompanied by hepatocyte proliferation and liver growth. The steroid hormone receptors superfamily have been identified that can be activated by peroxisome proliferators and are called Peroxisome Proliferator Activated Receptors (PPARs). It is therefore suggests that PPARs mediate the pleiotropic effects of peroxisome proliferators including enzyme induction, peroxisome proliferation, cell proliferation and hepatocarcinogenesis. Although the correlation of peroxisome proliferation and hepatocarcinogenesis is striking, the mechanism(s) by which this class of chemicals induce tumor is still understood; however several other hypothesis have been advanced. One is based on knowledge that hydrogen peroxide is produced during the increase in peroxisomal fatty acid oxidation. An excess of hydrogen peroxide can lead to oxidative stress (generation of reactive oxyden species), DNA damage and possibly to tumor initiation. In rodents, an alternative mechanism is the promotion of spontaneously initiated lesions by sustained cell proliferation. Thirdly, it is conceivable that sustained growth stimulation may be sufficient for tumor formation. Marked species differences are apparent in response to peroxisome proliferators. Rats an mice are extremely responsive species, and hamsters show an intermediate response, while guinea pigs, monkeys and humans appear to be relatively non-responsive. In the light of these data it seems likely that risk to humans from peroxisome proliferators may be overestimated. However, peroxiome proliferators have shown to produce the other effects such as the suppression of hepatocyte apoptosis which could be an important factor in their hepatocarcinogenic response.

摘要

过氧化物酶体增殖剂是一类多样的化学物质,被视为啮齿动物肝癌致癌物和/或肝脏肿瘤促进剂。这些化合物给予大鼠和小鼠后,会使肝脏过氧化物酶体的大小和数量显著增加,并使参与脂肪酸β氧化的酶活性增强。过氧化物酶体增殖伴随着肝细胞增殖和肝脏生长。已鉴定出类固醇激素受体超家族,其可被过氧化物酶体增殖剂激活,称为过氧化物酶体增殖物激活受体(PPARs)。因此表明PPARs介导过氧化物酶体增殖剂的多效性作用,包括酶诱导、过氧化物酶体增殖、细胞增殖和肝癌发生。尽管过氧化物酶体增殖与肝癌发生之间的相关性很显著,但这类化学物质诱导肿瘤的机制仍不清楚;然而,已经提出了其他几种假说。一种假说是基于这样的认识,即过氧化物酶体脂肪酸氧化增加时会产生过氧化氢。过量的过氧化氢会导致氧化应激(活性氧物种的产生)、DNA损伤,并可能引发肿瘤起始。在啮齿动物中,另一种机制是持续的细胞增殖促进自发起始的病变。第三,持续的生长刺激可能足以导致肿瘤形成。在对过氧化物酶体增殖剂的反应中,明显存在显著的物种差异。大鼠和小鼠是极其敏感的物种,仓鼠表现出中等反应,而豚鼠、猴子和人类似乎相对不敏感。根据这些数据,过氧化物酶体增殖剂对人类的风险可能被高估了。然而,过氧化物酶体增殖剂已被证明会产生其他作用,如抑制肝细胞凋亡,这可能是它们致癌反应中的一个重要因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验